Author:
Salas Maribel,Stricker Bruno
Publisher
Springer International Publishing
Reference77 articles.
1. Strom B, Kimmel S. Textbook of pharmacoepidemiology. Hoboken: Wiley; 2006.
2. Miller JL. Troglitazone withdrawn from market. Am J Health Syst Pharm. 2000;57:834.
3. Gale EA. Lessons from the glitazones: a story of drug development. Lancet. 2001;357:1870–5.
4. Scheen AJ. Thiazolidinediones and liver toxicity. Diabetes Metab. 2001;27:305–13.
5. Glessner MR, Heller DA. Changes in related drug class utilization after market withdrawal of cisapride. Am J Manag Care. 2002;8:243–50.